1Ferenci P,Caca K,Loudianos G,et al.Diagnosid and phenotypic classification of Wilson disease.Liver Int,2003,23:139-142.
2Schiefermeier M,Kollegger H,Madl C,et al.The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease.Brain,2000,123:585-590.
3Sun Y, Wu S, Bu G,et al.Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.J Neurosci,1998,18:3261-3272.
4Ferenci P,Caca K,Loudianos G,et al.Diagnosid and phenotypic classification of Wilson disease.Liver International,2003,23:139～142
5Thomas GR,Forbes JR,Roberts EA,et al.The Wilson disease gene spectrum of mutations and their consequences.Nat Genet,1995,9:210～217
6Walker JM,Tsivkovskii R,Lutsenko S,et al.Metallochaperone Atoxl transfers copper to the NH2-terminal domain of theWilson's disease protein and regulates its catalytic activity.J Biol Chem,2002,277:27953～27959
